BillionToOne (BLLN) vs Clover Health Investments (CLOV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BillionToOne is the larger company by market cap ($4.52 billion vs $2.42 billion), about 1.9 times the size. On valuation, Clover Health Investments trades at a lower forward P/E (30.4x vs 64.5x for BillionToOne). BillionToOne converts more of its revenue into profit, with a net margin of 2.4% versus -4.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLLN | CLOV |
|---|---|---|
| Share price | $95.75 | $4.56 |
| Market cap | $4.52B | $2.42B |
| 1-day change | -4.19% | -0.87% |
| YTD return | +17.00% | +94.04% |
| 1-year return | — | +68.89% |
| 5-year return | — | -42.35% |
| P/E ratio (TTM) | 151.98 | — |
| Forward P/E | 64.48 | 30.40 |
| EPS (TTM) | $0.63 | $-0.05 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $305.11M | $1.92B |
| Revenue growth (YoY) | +99.97% | +40.34% |
| Net income (latest FY) | $7.45M | $-85.55M |
| Gross margin | 68.32% | — |
| Operating margin | 5.25% | -4.44% |
| Net margin | 2.44% | -4.45% |
| 52-week high | $150.44 | $5.59 |
| 52-week low | $61.96 | $1.58 |
| Distance from 52-week high | -36.35% | -18.43% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +34.73% | +17.98% |
| Average volume | 696.43K | 4.27M |
| Shares outstanding | 42.64M | 435.44M |
| Employees | 713 | 724 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BillionToOne is more profitable, keeping 2.4 cents of every revenue dollar as net income versus -4.4 cents for Clover Health Investments.
- BillionToOne grew revenue faster in its latest fiscal year (+99.97% vs +40.34%).
About BillionToOne
BLLN stock →BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.
Health Care · Medical Specialities · 713 employees
About Clover Health Investments
CLOV stock →Clover Health Investments, Corp. provides medicare advantage plans in the United States.
Health Care · Medical Specialities · 724 employees
BLLN vs CLOV FAQ
Which is bigger, BillionToOne or Clover Health Investments?
BillionToOne (BLLN) is larger, with a market capitalization of $4.52B compared with $2.42B for Clover Health Investments (CLOV).
Are BillionToOne and Clover Health Investments in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.